Pharmalicensing Logo - Go to Home page
Seeking a Phase III End Oncology Focused Product with Improved Results Against Todays Existing Treatment of Choice
Leiras Takeda Pharmaceuticals Finland flag Finland
Abstract ID:
New cancer treatment modality with clearly improved treatment results for today´s treatment of choice
Send an Inquiry
RE:
Participants
You

-new cancer treatment modality with clearly improved treatment results for today´s treatment of choice


-areas where clear unmet medical needs exists

Type of Business Relationship Sought

No active co-funding or co-development role for Takeda in Nordics

FEATURED
Last Updated Sep 2014
Technology Type
Phase of Development CLINICAL TRIALS
CORPORATION
Leiras Takeda Pharmaceuticals
Paciuksenkatu 21 (LEIRAS)
PO Box 1406
Helsinki , FINLAND FIN-00101
Finland
Opportunity Contact
Leena Rinne
Project Manager
+358 20 746 501
Visit Website